Podcast Beta
Questions and Answers
Which key change was made in the revised 2022 WHO Classification for AML?
What is the primary basis for subdividing AML in the revised 2022 WHO Classification?
Which AML subtype was exempt from the elimination of the 20% blast requirement in the revised 2022 WHO Classification?
What is the significance of the introduction of 'AML with other de-fined genetic alterations' in the revised 2022 WHO Classification?
Signup and view all the answers
Study Notes
Revised 2022 WHO Classification for AML
- The revised 2022 WHO Classification for AML introduces a key change in the elimination of the 20% blast requirement, except for one subtype.
- The primary basis for subdividing AML in the revised 2022 WHO Classification is the genetic alterations.
- AML with t(8;21) is the AML subtype exempt from the elimination of the 20% blast requirement.
- The introduction of 'AML with other defined genetic alterations' in the revised 2022 WHO Classification is significant as it recognizes the genetic heterogeneity of AML and provides a more precise classification of the disease.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Learn about the key changes in the 2022 World Health Organisation (WHO) Classification of Acute Myeloid Leukemia (AML) including the subdivision into AML with defining genetic abnormalities (DGA) and AML defined by differentiation, and the elimination of the 20% blast requirement for certain AML types.
